Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective. - Wikidata - awgldk - TriplyDB

Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.

Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.

http://www.wikidata.org/entity/Q44401566

about

Bacterial infections in cirrhosis: A critical review and practical guidance A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management.Effects of Clostridium difficile infection in patients with alcoholic hepatitis.Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates.Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case-control study.Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding.Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis Emergency department visits related to cirrhosis: a retrospective study of the nationwide emergency department sample 2006 to 2011.Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation.Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.Diagnosis and management of bacterial infections in decompensated cirrhosis.Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin.Bacterial infections in end-stage liver disease: current challenges and future directions Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis.Novel prevention strategies for bacterial infections in cirrhosis.Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection.Is cirrhosis associated with lower odds of ischemic stroke: A nationwide analysis?Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysis.Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.New therapeutic paradigm for patients with cirrhosis.Proton pump inhibitor use and association with spontaneous bacterial peritonitis in patients with cirrhosis and ascites.Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review.The economic impact of Clostridium difficile infection: a systematic review.Keeping high model for end-stage liver disease score liver transplantation candidates alive.Clostridium difficile infection in patients with liver disease: a review.New antibiotic strategies in patients with cirrhosis and bacterial infection.Antibiotic prophylaxis in cirrhosis: Good and bad.Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study.Hospitalized Patients with Cirrhosis Should Be Screened for Clostridium difficile Colitis.Outcomes of Clostridium difficile infection in hospitalized leukemia patients: a nationwide analysis.

P2860

Q26766663-05C0EEEE-900C-41BE-B101-1A6ED41B2324 Q27335693-CE5B936B-C2C1-4CF9-BB42-308D6CCDDDD1 Q34225090-1AB1CA21-2217-45AE-8D30-BDF22A397CEA Q34306753-5A2DA238-AB80-48EC-A0C7-B5854C96F017 Q34510524-9B46697A-ACBE-4699-BF1B-A9764541CB01 Q34643177-BC5C94EC-E806-4B77-B0CF-3E4ED46E8B55 Q34660095-FDFD848B-683F-4BEC-AD14-84C5B5A76080 Q35079589-FD731072-6425-4559-BF41-733DC14539FC Q36002019-2246D6D7-72B4-4F54-93B8-DC56946C580F Q36113668-BDD7FA3B-EDA0-4229-806C-29E3061E8DCC Q36116938-3C8B6C57-E878-433F-A0D1-337DDE7F5A0B Q36152842-800C6D22-E087-494C-AC48-48067910A7A2 Q36217689-9FEA31D5-F31E-4026-9559-26B44791AF8A Q36258762-652E248A-8308-4500-B978-474D8508880B Q36381386-6DAF8F9B-ED8B-4D45-8CCE-249BDE82382C Q36472730-D6F1A69E-E390-4538-9871-B0E46F210354 Q36582826-5F2FAE25-65E5-4847-94E8-7A37F7C03AD9 Q36680914-5CD67319-4C59-4CB8-81B2-43A0F49CCB62 Q36705999-D52B1F01-252B-49AE-8D1B-D4F7C37ED6AA Q36892868-42198DCE-5F05-4BA5-A077-8F74565C87CF Q37049604-54D196F4-0191-4FDA-98D5-4E51AA18356C Q37183463-A44FB62A-5B09-4E5D-839F-082C431FEDFB Q37391438-6A2179AE-7F31-4A5A-91BA-A3CD43334684 Q37513102-6A053D8F-26D5-4B05-B9EF-15F87D3800ED Q37874694-B3399072-C1A1-41AA-BF57-56F00D458B93 Q38004673-F6273261-3B70-46EC-8207-66E6EE53C0A9 Q38021413-84192B29-BBDC-4F89-8246-1C0D5B759EA6 Q38049065-98CAFDDB-F464-466E-8EC8-D1BD03915118 Q38316544-0506A3B9-A365-4BDF-8862-052E284A1483 Q38409139-DE7AE836-BED4-4E62-9FF0-56C5CBC2B5EC Q38579840-1F146840-69CC-4D94-BA6F-2639BF6B4038 Q38600142-BC35A1DC-AB72-484D-A043-30286239DD2E Q38606723-A5F1799D-50C9-426B-8C76-B61AFDF022E8 Q38623328-EC8F6264-3106-4E2B-BC1C-B7B31F88C594 Q38661029-94A27E90-BAA6-41D8-8FBD-CA3CE5DD378D Q38787464-07526A61-30B0-4944-B023-26AFAD6AF74F Q39600494-6B00AE95-F867-42E0-B072-23CE5C7F6534 Q40293106-7DDE442E-0E74-4578-9345-75058F6D9BEC Q40926881-9B04206B-0FFF-4248-A8F0-F0E7013C72CD Q41175038-3F52EF59-C08D-43EF-BB34-3496F3D8B10D

P2860

Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.

http://www.wikidata.org/entity/Q44401566

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Clostridium difficile is assoc ...... d tertiary center perspective.

@en

Clostridium difficile is assoc ...... d tertiary center perspective.

@nl

type

label

Clostridium difficile is assoc ...... d tertiary center perspective.

@en

Clostridium difficile is assoc ...... d tertiary center perspective.

@nl

prefLabel

Clostridium difficile is assoc ...... d tertiary center perspective.

@en

Clostridium difficile is assoc ...... d tertiary center perspective.

@nl

P1433

Q44401566-5C63D384-28A2-4D68-9F71-567E93623421

P1476

Q44401566-0332064D-3950-41E7-BE1C-BBD6299C45C2

P2093

Q44401566-0ADC5655-A185-48A2-9410-1A879593B50B

Q44401566-148925C4-90BB-43C6-B48F-68AB0CFBBFB9

Q44401566-1FE4606D-C1EB-4C20-B88E-CF3A1AEFB78E

Q44401566-2669EEB1-F7D0-4485-976A-B8EE5C9FD892

Q44401566-28E1CD67-5597-45C5-A193-5EC2EA474C73

Q44401566-46B7D307-7014-4B5E-AFFD-CF7E36E055B7

Q44401566-A08B82AB-2885-4731-8219-42125AB05940

Q44401566-A4D10980-78AD-4643-938C-0CD6DE0AD815

Q44401566-B0ABFF92-2D8B-486D-9DFA-4BC150D5D310

Q44401566-C9FC7E1A-A172-47B4-BE49-B6B3AE42A242

P2860

Q44401566-0A718324-AC15-4A75-BE34-5E85F9D203D4

Q44401566-16921844-131D-41E5-9E50-AED1ED493DEB

Q44401566-3B729FD7-0675-48F7-ACD3-5C503A4D299D

Q44401566-43BA7179-B5F3-443A-BDDE-D94CE23590E3

Q44401566-5E5DB3B6-C9D0-40FF-A54D-BBFAC0E14600

Q44401566-62C01D09-BAA4-488C-B66D-F7E5189E1A22

Q44401566-65C528A6-6849-4B58-A27F-F0EE34395FB1

Q44401566-67777291-08C3-484B-8AA3-FFF4A20F048C

Q44401566-7C43E8D2-4D2E-4B34-AB28-F4F99419421F

Q44401566-94F2AEEF-53DA-4CCF-9F23-E6DE9C1BD6DC

P304

Q44401566-09CE15C1-8437-4463-8290-FC072BE8F4F4

P31

Q44401566-C35EE5E1-BB91-46B3-BA93-AA741EF8024C

P356

Q44401566-20E33000-F761-4321-A569-C3AC1AB86701

P407

Q44401566-9E29B9A5-9EE4-453A-B088-43658FB701E3

P433

Q44401566-210CA616-6B3C-4548-A070-CC3D661787DC

P478

Q44401566-56C7FFA6-6F7A-46A3-9C50-5B8DCE2D2794

P577

Q44401566-A61DF43E-E10B-4FF6-9985-01DC9B6478DF

P5875

Q44401566-2DCB2654-DA9B-45FB-A0DB-CC7BF77CD2BD

P698

Q44401566-F1BA2C7F-27B8-4CE8-9A16-F681AC9133C0

P921

Q44401566-C3DD3BA4-2116-4AC9-843A-CCCDA86B0139

Q44401566-DDF8E47F-DC99-4DB5-8D6A-6113E112A638

P356

P1433

The American Journal of Gastroenterology

P1476

Clostridium difficile is assoc ...... d tertiary center perspective.

@en

P2093

Alexis Dye

http://www.w3.org/2001/XMLSchema#string

Arun J Sanyal

http://www.w3.org/2001/XMLSchema#string

Ashwin N Ananthakrishnan

http://www.w3.org/2001/XMLSchema#string

Douglas Heuman

http://www.w3.org/2001/XMLSchema#string

Emily L McGinley

http://www.w3.org/2001/XMLSchema#string

Jasmohan S Bajaj

http://www.w3.org/2001/XMLSchema#string

Kia Saeian

http://www.w3.org/2001/XMLSchema#string

Muhammad Hafeezullah

http://www.w3.org/2001/XMLSchema#string

Raymond G Hoffmann

http://www.w3.org/2001/XMLSchema#string

Yelena Zadvornova

http://www.w3.org/2001/XMLSchema#string

P2860

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

The challenges posed by reemerging Clostridium difficile infection.

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Clostridium difficile--more difficult than ever.

Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999.

ICD-9 codes and surveillance for Clostridium difficile-associated disease

Emergence of Clostridium difficile-associated disease in North America and Europe.

Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005

P304

106-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJG.2009.615

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38025171

http://www.w3.org/2001/XMLSchema#string

P698

19844204

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile